alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.45  June 16, 2008  Dear Susan Marsch:  On June 6, 2008, the Compensation Committee of the Board of
Directors approved an award to you of restricted cash in the amount of
USD$400,000 (the Award).  The Award is
payable in three equal, annual installments, with the first payment of $133,334
(less applicable withholding) scheduled for June 1, 2009.  You must be employed by the Company through each
payment date in order to receive the payment due on that date.  In the event your
employment with the Company terminates in a manner that would entitle you to severance
benefits under the Executive Involuntary Termination Severance Pay Plan (the Plan)
in which you participate and a copy of which has been delivered to you by the
Company, your Award will vest in full and will be payable at the same time as the
cash severance benefits paid under the Plan are otherwise payable, and receipt
of the accelerated Award will be subject to the same terms and conditions as
the receipt of severance benefits under the Plan.  Those conditions include, but are not limited
to, the requirement that you execute a release in favor of the Company as
required by Section 4.3 of the Plan.  The acceleration and
subsequent payment of the Award in accordance with this letter agreement will
be in addition to and shall not be in lieu of any other severance or retention
plan benefits, and shall not reduce any payment you may otherwise be eligible
to receive, under the Plan.  Please acknowledge receipt of this agreement and your acceptance of the
terms hereof by signing below and returning the signed copy to the Human
Resources Department.  Sincerely,Mark GreenSVP, Global Human Resources and Real Estate  ACKNOWLEDGED AND AGREED TO:Signature:
  /s/ Susan MarschName printed:
  Susan MarschDate:  July 11, 2008
CERTIFICATION PURSUANT TO

18 U.S.C. Section 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

     

In connection with the Quarterly Report of **Great Walll Builders Ltd.,**(the "Company")on Form 10-Q/A for the period ended **September 30, 2010**as filed with the Securities and Exchange Commission on the date here of (the "report"), I, **Tian Jia,** Chief Executive Officer/ Chief Financial Officer/ Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Dated this date: May 25 2011.

 

 

/s/ Tian Jia

 

 

Tian Jia

 

 Chief Executive Officer & Chief Financial Officer &

Principal Accounting Officer
FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

SAMUEL VILLEGAS LOPEZ,

 Plaintiff - Appellant,

 v.

JANICE K BREWER, Governor of

Arizona; CHARLES L. RYAN, Director,

Arizona Department of Corrections; RON

CREDIO, Warden, Arizona Department of

Corrections - Eyman; LANCE R.

HETMER, named as: Lance

Hetmer/Warden, Arizona Department of

Corrections - Florence; UNKOWN

PARTIES, named as: IV Team Leader; IV

Team Members 1-5; Special Operations

Team Leader; Special Operations Team

Recorder; Special Operations Team

Members 1-5; and Does 1-25,

 Defendants - Appellees.

No. 12-16084

D.C. No. 2:12-cv-00245-NVW

District of Arizona, 

Phoenix

ORDER

Before: THOMAS, Circuit Judge and Capital Case Coordinator.

A panel of this Court issued an opinion affirming the district court’s denial

of petitioner’s motion for a preliminary injunction and denying his motion for a

stay of execution. Petitioner filed a petition for rehearing and rehearing en banc. 

The Warden elected not to file an optional response. 

FILED

MAY 15 2012

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
 Ordinarily an Order denying a Petition for Rehearing En Banc is not filed 1

until the Court ascertains whether any judge wishes to file a dissent from

Rehearing En Banc or a concurrence in the Order. Given the time constraints, this

Order is being filed forthwith. Dissents or concurrences will be filed for

publication later if a judge so requests. 

Pursuant to the rules applicable to capital cases when an execution date has

been scheduled, a deadline was established by which any judge could request a

vote on whether the panel's opinion should be reheard en banc. A judge timely

requested a vote on the petition for rehearing en banc. A majority of the judges

eligible to vote did not vote in favor of rehearing en banc. Judges Ikuta, Murguia,

and Nguyen were recused. 

Therefore, the Petition for Rehearing En Banc is DENIED. En banc

proceedings with respect to the panel opinion are concluded. The panel will issue 1

a separate order as to the petition for panel rehearing.
---

Exhibit 32.1

CERTIFICATION PURSUANT TO
  18 U.S.C. SECTION 1350, 
  AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of New Jersey Mining
  Company, (the "Company") on Form 10-KSB for the period ending December 31, 2004,
  as filed with the Securities and Exchange Commission on the date hereof (the
  "Report"), I, Fred W. Brackebusch, President, Treasurer and Director of New
  Jersey Mining Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted
  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements
        of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                       
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                                     
|(2) | The information contained in the Report fairly presents,
        in all material respects, the financial condition and results of operations
        of the Company.

Date:  June 14, 2005

By /s/ FRED W. BRACKEBUSCH 
  Fred W. Brackebusch, President, Treasurer & Director



[The balance of this page has been intentionally left blank.]

---
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           2,163
<SECURITIES>                                       111
<RECEIVABLES>                                   60,883
<ALLOWANCES>                                     1,670
<INVENTORY>                                     61,277
<CURRENT-ASSETS>                               137,564
<PP&E>                                          45,749
<DEPRECIATION>                                  10,584
<TOTAL-ASSETS>                                 484,136
<CURRENT-LIABILITIES>                           54,089
<BONDS>                                        314,414
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     110,020
<TOTAL-LIABILITY-AND-EQUITY>                   484,136
<SALES>                                        498,456
<TOTAL-REVENUES>                               498,456
<CGS>                                          340,909
<TOTAL-COSTS>                                  340,909
<OTHER-EXPENSES>                                 (283)
<LOSS-PROVISION>                                 1,123
<INTEREST-EXPENSE>                              28,524
<INCOME-PRETAX>                                 10,795
<INCOME-TAX>                                     6,641
<INCOME-CONTINUING>                             39,036
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  1,936
<CHANGES>                                            0
<NET-INCOME>                                     2,218
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
# Fourth Court of Appeals
San Antonio, Texas

September 2, 2016

No. 04

- 16

- 00063

- CV

TEAL TRADING AND DEVELOPMENT, LTD

.,

Appellant

v.

CHAMPEE SPRINGS RANCHES PROPERTY OWNERS ASSOCIATION

, Appellee

From the 216th Judicial District Court, Kendall County, Texas

Trial Court No. 06

- 500A Honorable N. Keith Williams, Judge P residing



### O R D E R

Appellant’s motion for extension of time to file its brief is GRANTED. Appellant’s brief is due on October 10, 2016. No further ext ensions will be granted

.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said
court on this 2nd day of September, 2016

.

___________________________________ Keith E. Hottle
Clerk of Court
Exhibit 32.1



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS

ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002



In connection with the Quarterly Report of Concord EFS, Inc. (the Company) on Form 10-Q for the period ended June 30, 2003, as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Dan M. Palmer, Co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:



(1)  The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.



By:

/s/    DAN M. PALMERDan M. Palmer Co-Chief Executive Officer




Dated:    August 11, 2003



A signed original of
this written statement required by Section 906 has been provided to Concord EFS, Inc. and will be retained by Concord EFS, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
**Exhibit 13.2**

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT 2002

 

This certification is not to be deemed filed pursuant to the Securities Exchange Act of 1934, as amended, and does not constitute a part of the Annual Report of UTStarcom Holdings Corp. (the “Company”) on Form 20-F for the period ending December 31, 2013 as filed with the Securities and Exchange Commission on April 18, 2014, as amended by this Amendment No. 1 on Form 20-F/A filed on the date hereof (the “Report”).

 

In connection with the Report, I, Tianruo Pu, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that:

 

(1)                                 The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)                                 The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
| Dated:   June 30, 2014 |                               |
|-----------------------------|------------------------------------|
|                        |                               |
| By:                         | /s/   Tianruo Pu                   |   |
|                        | Name:   Tianruo Pu                 |   |
|                        | Title:   *Chief Financial Officer* |   |

 

----
II

106TH CONGRESS

1ST SESSION S. 158

To amend title 18, United States Code, to regulate the manufacture,

importation, and sale of ammunition capable of piercing police body armor.

IN THE SENATE OF THE UNITED STATES

JANUARY 19, 1999

Mr. MOYNIHAN introduced the following bill; which was read twice and

referred to the Committee on the Judiciary

A BILL

To amend title 18, United States Code, to regulate the

manufacture, importation, and sale of ammunition capable of piercing police body armor.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Law Enforcement Offi5 cers Protection Amendment Act of 1999’’.

6 SEC. 2. EXPANSION OF THE DEFINITION OF ARMOR PIERC7 ING AMMUNITION.

8 Section 921(a)(17)(B) of title 18, United States

9 Code, is amended—

10 (1) by striking ‘‘or’’ at the end of clause (i);
2

•S 158 IS

1 (2) by striking the period at the end of clause

2 (ii) and inserting ‘‘; or’’; and

3 (3) by adding at the end the following:

4 ‘‘(iii) a projectile that may be used in

5 a handgun and that the Secretary of the

6 Treasury, in consultation with the Attor7 ney General determines, pursuant to sec8 tion 926(d), to be capable of penetrating

9 body armor.’’.

10 SEC. 3. DETERMINATION OF ARMOR PIERCING CAPABILITY

11 OF PROJECTILES.

12 Section 926 of title 18, United States Code, is

13 amended by adding at the end the following:

14 ‘‘(d) Not later than 1 year after the date of enact15 ment of this subsection, the Secretary shall promulgate

16 regulations based on standards to be developed by the Sec17 retary of the Treasury, in consultation with the Attorney

18 General, for the uniform testing of projectiles to determine

19 whether such projectiles are capable of penetrating Na20 tional Institute of Justice Level II–A body armor.’’.

21 SEC. 4. AUTHORIZATION OF APPROPRIATIONS.

22 There are authorized to be appropriated such sums

23 as may be necessary for the Secretary of the Treasury and

24 the Attorney General to—
3

•S 158 IS

1 (1) develop and implement performance stand2 ards for armor piercing ammunition; and

3 (2) promulgate regulations for performance

4 standards for armor piercing ammunition.

Æ
Division of Compensation Analysis and 

Support

Program Evaluation Report

Document Number: DCAS-PER-056

Effective Date: 9/12/2014

Revision No. 0

BWXT Virginia Page 1 of 2

Author: Signature on file Date: 9/12/2014 

 Dave Allen, HP Team Leader

Approval: Signature on file Date: 9/12/2014

 J.W. Neton, Associate Director for Science

Supersedes: None

RECORD OF ISSUE/REVISIONS

ISSUE 

AUTHORIZATION 

DATE

9/12/21014

EFFECTIVE 

DATE

9/12/2014

REV. NO. 

0

DESCRIPTION

New document to determine the effect 

on previously completed claims due to 

changes in methods used in BWXT 

claims.

1.0 Description

No Technical Basis Document was written for the BWXT site. However, methods used 

in one dose reconstruction were often carried forward to the next as applicable. Many of 

these utilized the ORAUT-OTIB-00070 depletion factor. OTIB-0070 was revised on 

3/5/2012, and this revision could affect previously completed BWXT claims. The OTIB0070 factors only affect dose reconstruction during residual contamination periods. 

BWXT has three separate contract periods with residual contamination periods after each. 

The residual contamination periods include the following years: 1960-1967, 1973-1984, 

and 2002- March 1, 2011.

Also, in 2010 an SEC was designated for BWXT that covered 1959 and 1968 through 

1972. In 2011 and additional SEC covering 1985 through 11/30/1994 was designated. 

2.0 Issue Evaluation

The depletion factor in ORAUT-OTIB-0070 is used to estimate the reduction in 

contamination levels during the residual period. The revision to OTIB-0070 changed this 

factor so that the contamination level is assumed to decrease more slowly. This results in

an increase in the dose estimate for most years of the residual period. 

3.0 Plan for Resolution or Corrective Action

The population of potentially affected claims includes those with employment in any of 

the residual contamination periods that were completed prior to the 3/5/2012 revision to 

OTIB-0070. A search of claims completed prior to that date with a probability of 

causation (POC) below 50% resulted in a list of 82 claims. A review of each claim 

indicated that four had employment only during the contract periods and were not 
Division of Compensation Analysis and 

Support

Program Evaluation Plan

Document Number: DCAS-PER-056

Effective Date: 9/12/2014 Revision No. 0 Page 2 of 2

affected by OTIB-0070. Those four claims were removed from further evaluation,

leaving 78 claims.

The doses for all 78 claims were recalculated using the revised OTIB-70 depletion factor. 

No claim had a probability of causation of greater than or equal to 50% as a result of this 

reanalysis. One claim, however, had probability of causation between 45% and 50%. 

For that claim, the IREP program was run 30 times at 10,000 iterations in accordance 

with NIOSH procedures. The probability of causation remained below 50%. 

NIOSH will provide the Department of Labor with the list of all the claims evaluated under 

this PER. Since all claims were below 50%, NIOSH will not request the return of any of the 

claims.
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 7
<LEGEND>
This schedule contains summary financial information extracted from OPL's
Consolidated Balance Sheets and the Statements of Consolidated Income and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<DEBT-HELD-FOR-SALE>                                 0
<DEBT-CARRYING-VALUE>                          245,580
<DEBT-MARKET-VALUE>                            268,730
<EQUITIES>                                   1,733,124
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                               2,479,432
<CASH>                                         391,171
<RECOVER-REINSURE>                              17,620
<DEFERRED-ACQUISITION>                          95,658
<TOTAL-ASSETS>                               5,014,599
<POLICY-LOSSES>                                      0
<UNEARNED-PREMIUMS>                            523,996
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                863,616
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        12,750
<OTHER-SE>                                   2,464,125
<TOTAL-LIABILITY-AND-EQUITY>                 5,014,599
<PREMIUMS>                                     285,522
<INVESTMENT-INCOME>                             29,512
<INVESTMENT-GAINS>                              39,509
<OTHER-INCOME>                                  65,958
<BENEFITS>                                     108,416
<UNDERWRITING-AMORTIZATION>                     24,080
<UNDERWRITING-OTHER>                                 0
<INCOME-PRETAX>                                 22,581
<INCOME-TAX>                                    (2,499)
<INCOME-CONTINUING>                             20,082
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    20,082
<EPS-BASIC>                                       0.16
<EPS-DILUTED>                                     0.16
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0


</TABLE>
EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

As of
January 29, 2009, we had the following wholly owned subsidiaries:

|                                   
|-----------------------------------
|1. Kirk Pharmaceuticals, LLC       
|2. ANDAPharm LLC                   
|3. Kirk Pharmaceuticals, Inc.      
|4. Andapharm, Inc.                 
|5. LipoGenics, Inc.                
|6. Bionutrics Health Products, Inc.
|7. Synovics Laboratories, Inc.     
|8. Nutrition Technology Corporation
|9. InCon International Ltd.        
|10. Cosmedics, Inc.                

---
Exhibit 32.1

Certification of Annual Report

Pursuant
to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned
officer of Renaissance Learning, Inc. (the Company), hereby certifies that,
to the undersigneds knowledge:

| |     |                                                                                                                                                                                                                           
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) | the
 Companys Annual Report on Form 10-K for the year ended December 31, 2008
 (the Report) fully complies with the requirements of Section 13(a) or
 15(d), as applicable, of the Securities Exchange Act of 1934; and
| |     |                                                                                                                                                                                                                           
| | (2) | the
 information contained in the Report fairly presents, in all material
 respects, the financial condition and results of operations of the Company.                                                                    

|                     |                                 | 
|-------------------- | ------------------------------- | 
|Dated: March 6, 2009 |                                 | 
|                     | /s/ Terrance
 D. Paul           | 
|                     | Name:
 Terrance D. Paul        
|                     | Title: Chief
 Executive Officer

THIS WRITTEN
STATEMENT ACCOMPANIES THIS REPORT PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002 AND SHALL NOT BE DEEMED TO BE FILED BY THE COMPANY FOR PURPOSES OF
THE SECURITES EXCHANGE ACT OF 1934.

---